Patent ID: 8304448

Claim:
A method for treating a metabolic disorder, comprising administering a therapeutically effective amount of a benzazole derivative represented by the following Chemical Formula 1 or a pharmaceutically acceptable salt thereof to a patient in need of treatment of metabolic disorder, wherein the metabolic disorder is obesity: (wherein, R 1 is one substituent at position C5 or C6 of a benzoxazole or benzimidazole ring, which is selected from a group consisting of H, COOR a , CONR b R c and SO 2 NH 2 , wherein R a is H or a C 1 ˜C 2 alkyl group, and R b and R c are independently selected from a group consisting of: a C 3 ˜C 5 heteroaryl group bearing at least one heteroatom selected from among N, O and S; a C 3 ˜C 5 heterocyclic group bearing at least one heteroatom selected from among N, O and S; a C 1 ˜C 5 alkyl group bearing a C 1 ˜C 3 alkyl-substituted amino group; H; an amino group; and a C 1 ˜C 3 alkyl group; R 2 is a C 1 ˜C 10 alkyl group, a halogen atom or a nitro group; R 3 is H or a halogen atom; and X is O or NH).